EZH2 inhibitor GSK343 inhibits sepsis-induced intestinal disorders

Enhancer of zeste homolog 2 (EZH2) is positively associated with poor clinical outcomes in a number of aggressive tumors. Recent studies have demonstrated that inhibition of EZH2 also suppressed the inflammatory response during sepsis. The present study aimed to investigate whether an inhibitor of E...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Exp Ther Med
Main Authors: Yue, Dongyou, Wang, Zhiying, Yang, Yongan, Hu, Zhenjun, Luo, Ganping, Wang, Fu
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2021
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7967880/
https://ncbi.nlm.nih.gov/pubmed/33747174
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9854
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki